Improving Outcomes of Hospitalized Elders and Caregivers

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

PHASE2

Total Enrollment

421 participants

Study Classification

INTERVENTIONAL

Study Start Date

2003-04-30

Study Completion Date

2009-03-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

In this study, an intervention is tested that is designed to improve the outcomes of hospitalized elders and family caregivers.

Study design:

* randomized, controlled study
* participants: 280 family caregivers aged 21 or above
* length of follow-up: 2 weeks and 2 months after hospitalization

Study hypothesis: In this randomized clinical trial, the following hypotheses will be tested:

1. Hospitalized elders whose family CGs receive the CARE program versus those who receive a comparison program will have better outcomes during and after hospitalization as measured by: (1) fewer incidents of dysfunctional syndrome; (2) shorter hospital stays; (3) lower readmission rates; (4) less depressive symptoms; (5) higher cognitive level; (6) less functional decline perceived by family CG; and (7) a closer relationship with their family CGs.
2. Family CGs of hospitalized elders who receive the CARE program will report: (1) More positive beliefs about their loved one's responses to hospitalization and their role in the hospital setting; (2) more positive emotional outcomes (less worry, anxiety, and depressive symptoms) during and after hospitalization; (3) More participation in their loved one's care during hospitalization; and (4) More positive role outcomes (more role reward, less role strain, more prepared for their loved one's care, and a closer relationship with their elderly relatives, both during and after hospitalization).
3. The proposed model to explain the effects of the CARE program on the process and outcomes of family CG coping and elderly patient outcomes will be supported for CGs and elderly patients.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Telephone Support for Dementia Caregivers

NCT00735800

Dementia

COMPLETED PHASE2

Powerful Tools for Caregivers of Dementia Patients

NCT02697721

Caregivers Dementia Alzheimer Disease

COMPLETED NA

Systematic Care for Informal Caregivers of Dementia Patients: An Efficient Approach?

NCT00147693

Dementia, Vascular Dementia Alzheimer Disease +1 more

COMPLETED NA

Educational Video to Improve Nursing Home Care in End-stage Dementia

NCT01774799

Advanced Dementia

COMPLETED NA

Coordinating Center for Caregiver Intervention Trial

NCT00177489

Dementia Alzheimer Disease

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

More than 12 million elderly people are hospitalized each year in the United Status, frequently resulting in functional decline. Family care of hospitalized elders is important given the increasing numbers of hospitalized elders, needs for elder care in the home after hospital discharge, and responsibilities of family caregivers for providing this care. Involving family caregivers in the hospital care of their loved one may result in positive outcomes for both the elderly patients and their family caregivers. However, there is a paucity of empirical studies that have been conducted to evaluate the effectiveness of interventions to enhance family participation in caring for hospitalized elders. In the proposed study, we will build upon our prior work that has demonstrated the positive effects of theoretically-driven interventions with families of hospitalized patients and older adults at home. Among the unique contributions of this study include: (a) a randomized controlled design, (b) testing of a theoretically-driven, reproducible intervention that can be easily translated into clinical practice and widely disseminated; (c) the testing of an explanatory model to explain the effects of the intervention, (d) a prospective cost-effectiveness analysis; and (e) an intervention that begins early in the hospital stay, and (f) measurement of both short- and more long-term outcomes, up to 2 months following hospital discharge.

The primary aim of this study is to evaluate the effects of a theoretically-driven, reproducible intervention (CARE: Creating Avenues for Relative Empowerment) on the process and outcomes of hospitalized elders and their family caregivers. The secondary aims are to: (a) explore what factors moderate the effects of the intervention program (e.g., social economic status and family preferences for care participation); and (b) determine the cost-effectiveness of the CARE program. A two-group experiment will be used with 280 family caregivers of hospitalized elders. Measures of both process and outcome variables will be included, such as family caregiver beliefs, anxiety, worry, depression, role outcomes, as well as elderly patients outcomes during hospitalization and after hospital discharge. Findings from a recent pilot study with 49 family caregiver-elders dyads support undertaking this full-scale clinical trial in that family caregivers who received the CARE program, versus those who received a comparison program, had more positive coping and role outcomes and their hospitalized elderly relatives had positive outcomes during and after hospitalization.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Acute Illness

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

1

Treatment group

Group Type EXPERIMENTAL

Care Project for Hospitalized Elders & Family Caregivers

Intervention Type BEHAVIORAL

Phase 1 in-hospital contact: Family caregivers complete baseline data, listen to a tape about helping the elderly relative cope with hospitalization, and work on a mutual agreement/identification of goals for participation in family member's hospital care (i.e., selection of two complications to focus on based on patient's illness condition)

Phase 2 pre-hospital discharge: Family caregivers listen to a second tape about coping with the hospital experience, participating in their family member's in-hospital care, and preparing for hospital discharge/transition to home

2

Comparison Group

Group Type ACTIVE_COMPARATOR

Comparison Group

Intervention Type BEHAVIORAL

Phase 1 in-hospital contact: Family caregivers complete baseline data and listen to an informational tape about hospital policies.

Phase 2 pre-hospital discharge: Family caregivers listen to a second informational tape about the hospital and medical center.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Care Project for Hospitalized Elders & Family Caregivers

Phase 1 in-hospital contact: Family caregivers complete baseline data, listen to a tape about helping the elderly relative cope with hospitalization, and work on a mutual agreement/identification of goals for participation in family member's hospital care (i.e., selection of two complications to focus on based on patient's illness condition)

Phase 2 pre-hospital discharge: Family caregivers listen to a second tape about coping with the hospital experience, participating in their family member's in-hospital care, and preparing for hospital discharge/transition to home

Intervention Type BEHAVIORAL

Comparison Group

Phase 1 in-hospital contact: Family caregivers complete baseline data and listen to an informational tape about hospital policies.

Phase 2 pre-hospital discharge: Family caregivers listen to a second informational tape about the hospital and medical center.

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* age of 21 years or above;
* have an elderly relative (65 years or above) admitted to the three study units within the past 24-48 hours; (c) are related to the patient by blood, marriage, adoption, or affinity as a significant other (e.g., life partner, close friend);
* are primary CGs;
* can read and speak English; and
* live within a 1-hour drive of the facility (60 miles).

Exclusion Criteria

* paid care providers;
* unable to complete the questionnaires or provide care because of their own mental or physical impairment;

Patient:

* dies during the hospital stay or within 2 months after discharge;
* is transferred from the Intensive Care Unit (ICU) and stayed in the ICU for more than 2 nights;
* is diagnosed with dementia;
* is admitted from a long-term care facility; and
* is hospitalized for longer than 30 days
* is staying longer than 6 weeks in a nursing home immediately after hospitalization.

Minimum Eligible Age

21 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes